Gutiérrez M.C., Comas Mutis R., Calfa G.D., Valdomero A. Perinatal protein restriction induces anhedonic-like behavior: disturbed hippocampal neurotrophic signaling and neuroplasticity in adult offspring. Hippocampus. 2025. https://doi.org/10.1002/hipo.70003

Gutiérrez M.C., Perondi MC., Tortoni G., Cragnolini A., Cuadra G.R., Valdomero A. Early protein restriction in rats induces anhedonia in adult offspring: a key role of BDNF-TrkB signaling in the nucleus accumbens shell. Neuropharmacology. 2024; 258:110099. doi: 10.1016/j.neuropharm.2024.110099.

Perinatal protein restriction impacts nuclear O-GalNAc glycosylation in cells of liver and brain structures of the rat.

Garay Y., Cejas R., Perondi M.C., Gutierrez M.C., Parodi P., Ferrero F.A., Lardone R.A., Valdomero A., Cuadra G.R., Irazoqui F.J. JNutr 153: 979-98, 2023. ISSN 0022-3166.

Perondi MC, Gutiérrez MC, Valdomero A, Cuadra GR. Perinatal protein deprivation facilitates morphine cross-sensitization to cocaine and enhances ΔFosB expression in adult rats. Behav Brain Res. 333: 203-210, 2017. doi: 10.1016/j.bbr.2017.06.051; ISSN 0166-4328.

Velázquez E, Valdomero A, Maldonado N, Orsingher OA, Cuadra GR. Perinatal protein deprivation facilitates accumbal ERK phosphorylation in cocaine-sensitized adult rats. Behav Brain Res 241: 222-227, 2013. doi:10.1016/j.bbr.2012.12.020; ISSN 0166-4328

Valdomero A, Bussolino D, Orsingher O, Cuadra G.Perinatal protein malnutrition enhances rewarding cocaine properties in adult rats. Neuroscience 137: 221-229, 2006. doi:10.1016/j.neuroscience.2005.08.055; ISSN 0306-4522

Valdomero A, Velázquez E, de Olmos S, de Olmos J, Orsingher OA, Cuadra GR. Increased rewarding properties of morphine in perinatally protein malnourished rats. Neuroscience 150: 449-458, 2007. doi:10.1016/j.neuroscience.2007.09.006; ISSN 0306-4522

Valdomero A, Isoardi N, Orsingher O, Cuadra G.Pharmacological reactivity to cocaine in adult rats undernourished at perinatal age: behavioral and neurochemical correlates.. Neuropharmacology 48 (4): 538-546, 2005. doi:10.1016/j.neuropharm.2004.11.011; ISSN 0028-3908